XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Class A [Member]
Common Stock [Member]
Common Class A [Member]
Retained Earnings [Member]
Common Class A [Member]
Parent [Member]
Common Class A [Member]
Common Class B [Member]
Common Stock [Member]
Common Class B [Member]
Retained Earnings [Member]
Common Class B [Member]
Parent [Member]
Common Class B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2021 64,662,000       18,598,000                      
Balance at Dec. 31, 2021                 $ 563 $ 470,750 $ (36,933) $ 1,031,582 $ 787 $ 1,466,749   $ 1,466,749
Stock options exercised and stock awards (in shares) 585,000                              
Stock options exercised and stock awards                 4 8,029       8,033   8,033
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan                   25,315       25,315   25,315
Vesting of restricted share awards         $ 457       3 (8,669)       (8,666)   (8,666)
Issuance of common stock under employee stock purchase plan (in shares) 201,000                              
Issuance of common stock under employee stock purchase plan                 2 5,217       5,219   5,219
Common stock repurchases (in shares) (1,930,000)       (930,000)                      
Common stock repurchases                     (93,997)     (93,997)   (93,997)
Cash dividends declared on common stock   $ (34,207) $ (34,207) $ (34,207)   $ (10,420) $ (10,420) $ (10,420)                
Reclassification of foreign currency translation related to equity method                         (601) (601)   (601)
Foreign currency translation adjustment                         (4,316) (4,316)   (4,316)
Noncontrolling interest equity                             $ 17,828 17,828
Net income                       391,382   391,382 703 392,085
Balance (in shares) at Dec. 31, 2022 63,518,000       18,125,000                      
Balance at Dec. 31, 2022                 572 500,642 (130,930) 1,378,337 (4,130) 1,744,491 18,531 1,763,022
Stock options exercised and stock awards (in shares) 822                              
Stock options exercised and stock awards                 6 12,120       12,126   12,126
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan                   30,354       30,354   30,354
Vesting of restricted share awards                 3 (7,018)       (7,015)   (7,015)
Issuance of common stock under employee stock purchase plan (in shares) 209,000                              
Issuance of common stock under employee stock purchase plan                 1 5,951       5,952   5,952
Common stock repurchases (in shares) (3,088,000)       (2,182,000)                      
Common stock repurchases                     (213,425)     (213,425)   (213,425)
Cash dividends declared on common stock   (38,727) (38,727) (38,727)   (11,896) (11,896) (11,896)                
Foreign currency translation adjustment                         1,967 1,967   1,967
Net income                       347,055   347,055 1,006 348,061
Vesting of restricted share awards (in shares)         421                      
Retirement of treasury shares and par value adjustment                 224 (3) 224,520 (224,744)   (3)   (3)
Balance (in shares) at Dec. 31, 2023 61,461,000       16,364,000                      
Balance at Dec. 31, 2023                 806 542,046 (119,835) 1,450,025 (2,163) 1,870,879 19,537 $ 1,890,416
Stock options exercised and stock awards (in shares) 1,243                             1,225,271
Stock options exercised and stock awards                 12 18,494       18,506   $ 18,506
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan                   30,350       30,350   30,350
Vesting of restricted share awards                 4 (10,116)       (10,112)   (10,112)
Issuance of common stock under employee stock purchase plan (in shares) 196,000                              
Issuance of common stock under employee stock purchase plan                 2 6,865       6,867   6,867
Common stock repurchases (in shares) (295)       (52)                      
Common stock repurchases                     (16,400)     (16,400)   (16,400)
Cash dividends declared on common stock   $ (43,449) $ (43,449) $ (43,449)   $ (12,115) $ (12,115) $ (12,115)                
Foreign currency translation adjustment                         (7,130) (7,130)   (7,130)
Net income                       304,153   304,153 817 304,970
Vesting of restricted share awards (in shares)         351,000                      
Balance (in shares) at Dec. 31, 2024 62,605,000       16,663,000                      
Balance at Dec. 31, 2024                 $ 824 $ 587,639 $ (136,235) $ 1,698,614 $ (9,293) $ 2,141,549 $ 20,354 $ 2,161,903